| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |